Recombinant IL20 (Fletikumab Biosimilar) antibody

Catalog No. ABIN7488031

The Mammalian Cells Monoclonal anti-IL20 (Fletikumab Biosimilar) antibody has been validated for . It is suitable to detect IL20 (Fletikumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL20 (Fletikumab Biosimilar) antibody (ABIN7488031)

Target: IL20 (Fletikumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL20 (Fletikumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL20 (Fletikumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Fletikumab Biosimilar - Anti-IL20 mAb

Characteristics: Antibody Type: IgG4-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG4

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IL20 (Fletikumab Biosimilar)

Target: IL20 (Fletikumab Biosimilar)

Target Type: Biosimilar

Background: 15D2,NN-8226,NNC-0109-0012